Lineage, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lineage, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.36B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.34B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $5.34B | Feb 25, 2026 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.34B | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | $5.34B | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $4.93B | Feb 26, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($100.00M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($664.00M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($77.00M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($63.00M) | Feb 26, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $181.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($361.00M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $398.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $297.00M | Feb 26, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $943.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $703.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $796.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $501.00M | Feb 26, 2025 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $747.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $691.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $766.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $813.00M | Feb 26, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.19B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $18.66B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $18.87B | Feb 26, 2025 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.94B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $8.97B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $12.85B | Feb 26, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.25B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $8.64B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $5.05B | Feb 26, 2025 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.47B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.34B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.39B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $3.31B | Feb 26, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.44B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.86B) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($879.00M) | Feb 26, 2025 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $173.00M | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | $68.00M | Feb 26, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 226.97M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 228.19M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 162.02M | Feb 26, 2025 |